CD274 and neoplasm: However, as described for PET imaging of PD-L1 with 89Zr-labeled Atezolizumab [22], 89Zr-labeled anti-huLAG-3 antibody (REGN3767) only obtained optimal tumor-to-blood ratios days to 1 week after injection.